[Results of treatment of salt-losing adrenogenital syndrome with 9-alpha-fluorohydrocortisone].
D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D005438:Fludrocortisone / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male
D005438:Fludrocortisone
Wyniki leczenia zespołu nadnerczowo-płciowego z ultrata soli fluoro-pochodnymi kortyzonu.